Scilex Holding (SCLX) Cash from Operations (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Scilex Holding 58.57 Mn -91.35 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 106.30%
Dec 31, 2025 -313.40%
Sep 30, 2025 15.42%
Jun 30, 2025 18.08%
Mar 31, 2025 137.06%
Dec 31, 2024 -50.44%
Sep 30, 2024 121.25%
Jun 30, 2024 -75.39%
Mar 31, 2024 274.23%
Dec 31, 2023 -191.36%
Sep 30, 2023 143.79%
Jun 30, 2023 -73.98%
Mar 31, 2023 -968.14%
Dec 31, 2022 -128.62%
Sep 30, 2022 120.54%
Jun 30, 2022 -14.95%
Mar 31, 2022 61.63%
Dec 31, 2021 -19,600.37%
Sep 30, 2021 74.26%
Jun 30, 2021 -11.59%